Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial
暂无分享，去创建一个
J. Haughney | V. Libri | J. Nguyen-Van-Tam | L. Janani | P. Aley | Victoria J Cornelius | E. Thomson | D. Saralaya | C. Jones | M. Llewelyn | Daniel R Owens | M. Snape | A. Goodman | Shirley Todd | Y. Mujadidi | Krishna Chatterjee | T. Lambe | T. Rampling | S. Faust | B. Hallis | A. Minassian | G. Babbage | K. Cathie | S. Charlton | Xinxue Liu | A. Munro | Mihaela Pacurar | Stephen Saich | C. Green | O. Osanlou | A. Palfreeman | A. Hicks | N. Andrews | A. A. van der Klaauw | R. Sheridan | D. Pan | C. Twelves | S. Sharma | R. Read | A. Wright | Lauren M. Fox | M. Bula | M. Ramsay | D. Baxter | R. Osanlou | Mina H. Maallah | K. Regan | Tanveer Bawa | Kyra Holliday | Ehsaan Qureshi | S. Feng | Kate Dodd | Y. Enever | P. Moore | M. Mughal | Jonathan Baker | Matthew Stokes | Nasir Kanji | Alastair C Mcgregor | R. Mansfield | H. Belhadef